HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

oblimersen (G3139)

targets the Bcl-2 oncogene good efficacy with low toxicity tumour regressions
Also Known As:
G3139; G 3139; G-3139 oligonucleotide; G3139 oligonucleotide; Genasense; bcl-2 antisense oligodeoxynucleotide; oblimersen sodium
Networked: 145 relevant articles (16 outcomes, 73 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Stein, C A: 15 articles (04/2009 - 12/2001)
2. Benimetskaya, Luba: 12 articles (04/2009 - 10/2003)
3. Marcucci, Guido: 10 articles (01/2010 - 01/2003)
4. Liu, Shujun: 9 articles (01/2010 - 04/2005)
5. Miller, Paul: 9 articles (04/2009 - 05/2004)
6. Lee, Robert J: 8 articles (06/2011 - 05/2006)
7. Lai, Johnathan C: 7 articles (04/2007 - 05/2004)
8. Yu, Bo: 6 articles (06/2011 - 06/2009)
9. Lee, L James: 6 articles (06/2011 - 06/2009)
10. Chanan-Khan, Asher: 5 articles (06/2011 - 11/2004)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Neoplasms (Cancer)
3. Prostatic Neoplasms (Prostate Cancer)
4. Lymphoma (Lymphomas)
5. Multiple Myeloma

Related Drugs and Biologics

1. oblimersen (G3139)
2. Dacarbazine (DIC)
3. docetaxel (Taxotere)
4. Doxorubicin (Adriamycin)
5. Hormones
6. Cyclophosphamide (Cytoxan)
7. rituximab (Mabthera)
8. L-Lactate Dehydrogenase (Lactate Dehydrogenase)
9. Oligodeoxyribonucleotides
10. Codon (Codons)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Combination Drug Therapy (Combination Chemotherapy)
4. Intravenous Infusions
5. Castration